GE HealthCare Photonova Spectra Gains CE Mark for CT
CHICAGO, August 31, 2026 GE HealthCare announced that its Photonovaâ„¢ Spectra photon-counting computed tomography (PCCT) system has received CE...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CHICAGO, August 31, 2026 GE HealthCare announced that its Photonovaâ„¢ Spectra photon-counting computed tomography (PCCT) system has received CE...
Oslo, Norway, August 14, 2026 Photocure ASA has welcomed a new proposal from the U.S. Food and Drug Administration...
New York, New York, August 13, 2026 Aidoc announced that its CAREâ„¢ Body CT Multi-Triage has received eligibility for...
LAUSANNE, Switzerland, July 30, 2026 AB2 Bio Ltd. has reached a major commercial and regulatory milestone after Nippon Shinyaku...
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
OXFORD, United Kingdom, and ST. PETERSBURG, Fla., July 20, 2026 Adaptix Ltd. announced a strategic U.S. distribution partnership with...
TAMPA, Fla., July 16, 2026 PainTEQ has unveiled new scientific evidence supporting its cortical-piercing posterior sacroiliac (SI) joint fixation...
EAGAN, Minn., June 9, 2026 Sonex Health, Inc. and The Institute of Advanced Ultrasound Guided Procedures have announced the...
MENLO PARK, Calif., June 10, 2026 Subtle Medical has received U.S. FDA clearance for SubtleHDâ„¢(CT), a new artificial intelligence-powered...
REYKJAVIK, Iceland, June 4, 2026 Alvotech has announced the resubmission of U.S. Biologics License Applications (BLAs) for two important...
